ATE201880T1 - Oberflächenaktive zusammensetzungen und verfahren - Google Patents

Oberflächenaktive zusammensetzungen und verfahren

Info

Publication number
ATE201880T1
ATE201880T1 AT90911834T AT90911834T ATE201880T1 AT E201880 T1 ATE201880 T1 AT E201880T1 AT 90911834 T AT90911834 T AT 90911834T AT 90911834 T AT90911834 T AT 90911834T AT E201880 T1 ATE201880 T1 AT E201880T1
Authority
AT
Austria
Prior art keywords
methods
active compositions
assay
formulation
compositions
Prior art date
Application number
AT90911834T
Other languages
English (en)
Inventor
Bradley J Benson
John H Frenz
Cynthia P Quan
Steven Shak
Kathleen A Shiffer
John T Stults
Michael C Venuti
Original Assignee
Genentech Inc
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Byk Gulden Lomberg Chem Fab filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE201880T1 publication Critical patent/ATE201880T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT90911834T 1989-07-11 1990-07-10 Oberflächenaktive zusammensetzungen und verfahren ATE201880T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37868889A 1989-07-11 1989-07-11
PCT/US1990/003856 WO1991000871A1 (en) 1989-07-11 1990-07-10 Surfactant compositions and methods

Publications (1)

Publication Number Publication Date
ATE201880T1 true ATE201880T1 (de) 2001-06-15

Family

ID=23494139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90911834T ATE201880T1 (de) 1989-07-11 1990-07-10 Oberflächenaktive zusammensetzungen und verfahren

Country Status (8)

Country Link
EP (1) EP0482097B1 (de)
JP (1) JPH04506809A (de)
AT (1) ATE201880T1 (de)
AU (1) AU638474B2 (de)
DE (1) DE69033745T2 (de)
DK (1) DK0482097T3 (de)
ES (1) ES2157886T3 (de)
WO (1) WO1991000871A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
EP0458167B1 (de) * 1990-05-21 1997-04-23 Abbott Laboratories Fettsäure-Oberflächenaktives-Lungenprotein Konjate
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
CZ292186B6 (cs) 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
ATE292800T1 (de) 1998-07-24 2005-04-15 Altana Pharma Ag Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
ES2488692T3 (es) * 1998-10-20 2014-08-28 Children's Hospital Medical Center Proteína D tensioactiva para la prevención y el diagnóstico del enfisema pulmonar
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
CA2383140C (en) 1999-09-24 2007-12-04 Kyorin Pharmaceutical Co., Ltd. Ppar.alpha. and ppar.gamma. inhibitors
WO2001039573A2 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von lungensurfactant zur behandlung von legionärskrankheit
WO2003033014A2 (de) 2001-10-11 2003-04-24 Altana Pharma Ag Neue verwendung von lungensurfactant
KR20110017465A (ko) * 2002-04-25 2011-02-21 더 스크립스 리서치 인스티튜트 폐질환 증상의 치료 및 예방
SE0203591D0 (sv) 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CA2619079C (en) * 2005-05-11 2013-08-06 Yamasa Corporation Method of stabilizing pulmonary surfactant protein
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
AU2011295165B2 (en) 2010-08-23 2015-07-02 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Humidified particles comprising a therapeutically active substance
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use

Also Published As

Publication number Publication date
WO1991000871A1 (en) 1991-01-24
EP0482097B1 (de) 2001-06-06
DE69033745T2 (de) 2002-02-28
AU6066690A (en) 1991-02-06
DK0482097T3 (da) 2001-09-17
AU638474B2 (en) 1993-07-01
DE69033745D1 (de) 2001-07-12
ES2157886T3 (es) 2001-09-01
EP0482097A1 (de) 1992-04-29
JPH04506809A (ja) 1992-11-26

Similar Documents

Publication Publication Date Title
DE69033745D1 (de) Oberflächenaktive zusammensetzungen und verfahren
FI922151A0 (fi) Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
ES2157344T3 (es) Pirrolo(2,3-d)pirimidinas y su uso.
DK173883D0 (da) Substituerede 8-phenylxanthiner
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
FI884720A7 (fi) Varjoaineina käytettäviä koostumuksia
CA2063273A1 (en) Surfactant compositions and methods
ES2022832B3 (es) Procedimiento para la obtencion de cloruros de 3 imerizados.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
ES2041617T3 (es) Productos intermedios para agentes de quelacion con simetria prefijada y procedimiento para su preparacion.
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
ES2148142T3 (es) Compuestos de 2-aril-5-(trifluorometil)-2-pirrolina y procedimiento para la fabricacion de insecticidas de 2-aril-1-(alcoximetil)-4-halo-5-(trifluorometil)pirrol.
ES2056381T3 (es) Preparacion de intermedios diazabiciclos.
DK351484D0 (da) Pyrazolo(3,4,5-kl)acridinforbindelser, deres fremstilling og anvendelse
ES525297A0 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IT1241396B (it) Composizioni tensioattive, loro preparazione e loro impiego come agenti antischiuma. (caso 150-5294)
SE8502865L (sv) Naftoxaziner, deras framstellning och anvendning
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time